The weekly litigation news digest is live. Subscribe now

IP Verse

Cytokine Derived Treatment With Reduced Vascular Leak Syndrome

Patent No. EP2986312 (titled "Cytokine Derived Treatment With Reduced Vascular Leak Syndrome") was filed by Cytune Pharma on Apr 22, 2014. The application was issued on Dec 15, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SANOFISep 14, 2022ZWICKER
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBSep 14, 2022WICHMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2986312

CYTUNE PHARMA
Application Number
EP14723324A
Filing Date
Apr 22, 2014
Status
Granted And Under Opposition
Nov 12, 2021
Publication Date
Dec 15, 2021
External Links
Slate, Register, Google Patents